Td Waterhouse Canada Inc. Invitae Corp Transaction History

Td Waterhouse Canada Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.01 - $0.61 $460 - $28,060	-46,000 Closed	0 $0
Q4 2023 Feb 12, 2024	SELL	$0.42 - $0.72 $42 - $72	-100 Reduced 0.22%	46,000 $26 Million
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $636 - $1,621	-1,060 Reduced 2.25%	46,100 $33.3 Million
Q2 2023 Nov 13, 2023	BUY	$1.05 - $1.63 $1,113 - $1,727	1,060 Added 2.3%	47,160 $57 Million
Q1 2023 Nov 13, 2023	BUY	$1.2 - $2.73 $27,600 - $62,790	23,000 Added 99.57%	46,100 $63.6 Million
Q3 2022 Nov 13, 2023	BUY	$1.9 - $8.63 $43,624 - $198,144	22,960 Added 16400.0%	23,100 $60.8 Million
Q2 2022 Nov 13, 2023	BUY	$2.13 - $9.01 $85 - $360	40 Added 40.0%	140 $429,000
Q1 2022 Nov 13, 2023	SELL	$6.28 - $15.59 $8,164 - $20,267	-1,300 Reduced 92.86%	100 $1.06 Million
Q4 2021 Nov 13, 2023	BUY	$14.7 - $28.67 $20,580 - $40,138	1,400 New	1,400 $20.5 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.